SOLAZYME INC COM STK (DE)
SZYM
SZYM was delisted on the 10th of May, 2016.
0 hedge funds and large institutions have $0 invested in SOLAZYME INC COM STK (DE) in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 98 closing their positions.
100% less funds holding
Funds holding: 99 → 0 (-99)
100% less capital invested
Capital invested by funds: $63.9M → $0 (-$63.9M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 98
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$24.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.48M |
| 3 |
GA
Glenhill Advisors
New York
|
-$4.51M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$4.32M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.24M |
SZYM Hedge Fund Activity: Q2 2016 in Review
0 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in SOLAZYME INC COM STK (DE) (SZYM) for Q2 2016, worth a combined $0 — down 100% from $63.9M a quarter earlier.
Sellers outnumbered buyers: 98 funds closed out of SZYM and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Primecap Management, exiting entirely with an estimated $24.5M sold.
- 0 institutional investors held SOLAZYME INC COM STK (DE) (SZYM) as of Q2 2016, down from 99 in Q1 2016.
- Funds reported $0 of SOLAZYME INC COM STK (DE) stock for Q2 2016, down 100% quarter-over-quarter.
- 0 funds opened new SOLAZYME INC COM STK (DE) positions in Q2 2016 and 98 closed out, a net change of -98 holders.
- The largest SOLAZYME INC COM STK (DE) seller in Q2 2016 was Primecap Management, an estimated $24.5M sold.
Based on aggregated 13F filings for Q2 2016.